Youpei Lin
0000-0002-2914-2075
Publication & Citation Trends
Publications
0 total
Targeting MUC16 Suppresses Malignant Progression and Chemoresistance in Large-duct Type Intrahepatic Cholangiocarcinoma.
Cited by 0
Semantic Scholar
Robust transcriptomic hallmarks targeting intratumor heterogeneity in intrahepatic cholangiocarcinoma
Cited by 0
Semantic Scholar
Arachidonic Acid Metabolism in PMN-MDSCs Suppresses Antitumor Capacity of T cells in KRAS-Mutant Cholangiocarcinoma
Cited by 0
Semantic Scholar
AGEs-RAGE manipulates tumor intrinsic pERK/Sp1/IL6 pathway and reprograms macrophage to promote intrahepatic cholangiocarcinoma progression
Cited by 2
Semantic Scholar
Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma OA
Cited by 35
Semantic Scholar
Integrated Multi-Omics Profiling Identifies PDZ-Binding Kinase (PBK) as a Novel Prognostic Biomarker in Hepatocellular Carcinoma
Cited by 1
Semantic Scholar
Exploration of multi-omics liquid biopsy approaches for multi-cancer early detection: The PROMISE study.
Cited by 3
Semantic Scholar
Harnessing alternative splicing for off-the-shelf mRNA neoantigen vaccines in hepatocellular carcinoma
Cited by 3
Semantic Scholar
Research Topics
Cholangiocarcinoma and Gallbladder Cancer Studies
(112)
RNA modifications and cancer
(52)
Pediatric Hepatobiliary Diseases and Treatments
(35)
Peptidase Inhibition and Analysis
(26)
Cancer Immunotherapy and Biomarkers
(22)
Affiliations
Fudan University
Cancer Institute (WIA)
Zhongshan Hospital
Ministry of Education